Compare PRCH & PLSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PRCH | PLSE |
|---|---|---|
| Founded | 2012 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 880.9M | 1.5B |
| IPO Year | 2019 | 2015 |
| Metric | PRCH | PLSE |
|---|---|---|
| Price | $8.09 | $18.81 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 1 |
| Target Price | $17.11 | ★ $22.00 |
| AVG Volume (30 Days) | ★ 2.0M | 516.4K |
| Earning Date | 05-13-2026 | 06-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 90.91 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $482,414,000.00 | N/A |
| Revenue This Year | $2.37 | $883.71 |
| Revenue Next Year | $16.96 | $225.88 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 10.18 | N/A |
| 52 Week Low | $4.65 | $12.56 |
| 52 Week High | $19.44 | $26.30 |
| Indicator | PRCH | PLSE |
|---|---|---|
| Relative Strength Index (RSI) | 51.04 | 48.68 |
| Support Level | $6.36 | $13.75 |
| Resistance Level | $9.89 | $20.40 |
| Average True Range (ATR) | 0.63 | 1.83 |
| MACD | 0.08 | -0.68 |
| Stochastic Oscillator | 44.64 | 10.53 |
Porch Group Inc is a vertical software company reinventing the home services and insurance industries. It has two reportable segments: The vertical Software segment provides software and services to home services companies. The Vertical Software segment software and services provide inspection, mortgage, and title companies on a subscription and transactional basis, several key businesses, including inspection software and services, title insurance software, mortgage software, moving services, mover and homeowner marketing, and measurement software for roofers. The insurance segment provides consumers with insurance and warranty products to protect their homes, earning revenue through premiums collected on policies, policy fees, and commissions. Majority revenue is from Insurance segment.
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled.